Publications by authors named "Takeru Yoshimura"

Claim this Profile
C
Crucial role of P2X receptor for effector T cell activation in experimental autoimmune uveitis.
Atsunobu Takeda, Hisakata Yamada, Eiichi Hasegawa, Mitsuru Arima, Shoji Notomi, Takeru Yoshimura

Jpn J Ophthalmol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.
Han Zhang, Yang Yang, Atsunobu Takeda, Takeru Yoshimura, Yuji Oshima

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization.
Yedi Zhou, Shigeo Yoshida, Yuki Kubo, Takeru Yoshimura, Yoshiyuki Kobayashi

Mol Med Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Expression Analysis of the Irrigation Solution Samples Collected during Vitrectomy for Idiopathic Epiretinal Membrane.
Sayaka Myojin, Takeru Yoshimura, Shigeo Yoshida, Atsunobu Takeda, Yusuke Murakami

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function.
Hiromi Shoda, Ryoji Yanai, Takeru Yoshimura, Tomohiko Nagai, Kazuhiro Kimura

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
Yedi Zhou, Shigeo Yoshida, Shintaro Nakao, Takeru Yoshimura, Yoshiyuki Kobayashi

Invest Ophthalmol Vis Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
Yedi Zhou, Shigeo Yoshida, Shintaro Nakao, Takeru Yoshimura, Yoshiyuki Kobayashi

Invest Ophthalmol Vis Sci· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pathophysiology and new treatment of uveitis].
Ryoji Yanai, Atsunobu Takeda, Takeru Yoshimura, Koh-Hei Sonoda

Nihon Rinsho Meneki Gakkai Kaishi· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-10 is significantly involved in HSP70-regulation of experimental subretinal fibrosis.
Yang Yang, Atsunobu Takeda, Takeru Yoshimura, Yuji Oshima, Koh-Hei Sonoda

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
Atsunobu Takeda, Eiichi Hasegawa, Takako Fukuhara, Sayaka Hirakawa, Hisakata Yamada, Takeru Yoshimura

Exp Eye Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case report of malignant lymphoma receiving infliximab therapy with Behçet's disease].
Koh-Hei Sonoda, Takako Fukuhara, Horoshi Yoshikawa, Atsunobu Takeda, Takeru Yoshimura

Nippon Ganka Gakkai Zasshi· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of autoimmune retinal inflammation by an antiangiogenic drug.
Takeru Yoshimura, Ofra Benny, Lauren Bazinet, Robert J D'Amato

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.
Irit Adini, Kaustabh Ghosh, Avner Adini, Zai-Long Chi, Takeru Yoshimura

J Clin Invest· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization.
Eiichi Hasegawa, Koh-Hei Sonoda, Takashi Shichita, Rimpei Morita, Takashi Sekiya, Takeru Yoshimura, Akihiko Yoshimura

J Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of periostin in regression of hyaloidvascular system during ocular development.
Mitsuru Arima, Shigeo Yoshida, Takahito Nakama, Keijiro Ishikawa, Shintaro Nakao, Takeru Yoshimura

Invest Ophthalmol Vis Sci· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis.
Jun Suzuki, Takeru Yoshimura, Marina Simeonova, Kimio Takeuchi, Yusuke Murakami

Invest Ophthalmol Vis Sci· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis.
Kenji Nagata, Kazuichi Maruyama, Kazuko Uno, Katsuhiko Shinomiya, Kazuhito Yoneda, Takeru Yoshimura

Invest Ophthalmol Vis Sci· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
Hiroshi Kunikata, Masahiko Shimura, Toru Nakazawa, Koh-Hei Sonoda, Takeru Yoshimura

Acta Ophthalmol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice.
Koh-Hei Sonoda, Takeru Yoshimura, Kensuke Egashira, Israel F Charo, Tatsuro Ishibashi

Acta Ophthalmol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
Ofra Benny, Kei Nakai, Takeru Yoshimura, Lauren Bazinet, James D Akula

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
Takeru Yoshimura, Koh-hei Sonoda, Mika Sugahara, Yasutaka Mochizuki, Hiroshi Enaida

PLoS One· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Bruce Turpie, Takeru Yoshimura, Abha Gulati, Jose David Rios, Darlene A Dartt

Am J Pathol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased IkappaB alpha expression is essential for the tolerogenic property of TGF-beta-exposed APCs.
Paiman Ghafoori, Takeru Yoshimura, Bruce Turpie, Sharmila Masli

FASEB J· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
Takeru Yoshimura, Koh-Hei Sonoda, Nobuyuki Ohguro, Yoshiyuki Ohsugi, Tatsuro Ishibashi, Akihiko Yoshimura

Rheumatology (Oxford)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
Takeru Yoshimura, Koh-Hei Sonoda, Yoshiyuki Miyazaki, Yoichiro Iwakura, Tatsuro Ishibashi, Akihiko Yoshimura

Int Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis